NASDAQ · OSA
ProSomnus, Inc.
$0.47$0.00 (0.0%)
ProSomnus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 6.0% below the high.
Loading market information…
OTC · VEGGD · USD
Stock price, earnings
Quote as of Nov 18, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Better Plant Sciences Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Better Plant Sciences Inc., along with its subsidiaries, specializes in the development, promotion, and sale of plant-derived goods aimed at health and well-being. Serving markets across Canada and the United States, their extensive product portfolio encompasses various categories. These include plant-based beverages such as cold-pressed juices, cleansing programs, and booster shots; a comprehensive range of personal care items spanning skincare, haircare, body care, and infant care; and eco-friendly home cleaning solutions. The company also manufactures and supplies plant-based frozen meals. Furthermore, under the NeonMind brand, they offer a selection of mushroom-based consumer products. Complementing its product lines, Better Plant Sciences Inc. operates Jusu Bar, a chain of quick-service restaurants leveraging the Jusu brand. Their offerings are accessible through both traditional retail channels and direct-to-consumer e-commerce platforms. Established in 2014, the Vancouver, Canada-based enterprise was previously known as The Yield Growth Corp. until its rebranding to Better Plant Sciences Inc. in August 2020.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:21 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.47$0.00 (0.0%)
ProSomnus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 6.0% below the high.
$0.00$0.00 (0.0%)
CuraScientific Corp: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00-$0.82 (-99.99%)
Phoenix Life Sciences International Limited: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.01$0.00 (0.0%)
NantHealth, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.0% below the high.
CA$0.02+CA$0.01 (+50.0%)
Aquarius Surgical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 25.0% below the high.
$0.00+$0.00 (+900.0%)
Vitalibis, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00+$0.00 (+179,899.98%)
Pivotal Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.29% below the high.
$0.00-$0.02 (-79.91%)
Digicann Ventures Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.78% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
